SHANGHAI, July 22, 2024 — The molecular design strategy and experimental results of Bright Gene’s dual GLP-1/GIP receptor agonist, BGM0504,…
Read MoreSHANGHAI, July 22, 2024 — The molecular design strategy and experimental results of Bright Gene’s dual GLP-1/GIP receptor agonist, BGM0504,…
Read More